Unlocking the Potential of Immunotherapy in Breast Cancer – OncLive
OncLive |
Unlocking the Potential of Immunotherapy in Breast Cancer
OncLive Recent immunotherapy trials have produced mixed results in patients with breast cancer. A pair of trials that used checkpoint inhibitors as monotherapy reported lackluster overall response rates (ORRs). Trials that paired immunotherapy with … |
